For release: 29 November genedrive plc ("genedrive" or the "Company") AbbVie sponsored REACH study for the use of Genedrive HCV assay in pharmacies genedrive plc (AIM: GDR), the near patient molecular diagnostics company, today announces that it will participate in an international multicentre trial (‘REACH’) to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy setting versus conventional treatment pathways. The study, led by Prof. John Dillon, Professor of Hepatology...